Skip to main content
. 2022 Jun 30;12(7):1093. doi: 10.3390/jpm12071093

Figure 1.

Figure 1

Established and proposed biomarkers in the management of severe eosinophlic asthma (EDN: eosinophil-derived neurotoxin, EPO: eosinophil peroxidase, EBC: exhaled breath condensate).